跳至主要内容
临床试验/NCT01922765
NCT01922765Unknown4 期

Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori

The Catholic University of Korea1 个研究点 分布在 1 个国家目标入组 540 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
540
试验地点
1
主要终点
Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori

研究概览

简要总结

If we compare eradication rate of Helicobacter pylori divided to 4 groups: amoxicillin, rabeprazole, clarithromycin(AOC), amoxicillin, rabeprazole, metronidazole(AOM), treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days(sequential), amoxicillin, clarithromycin, metronidazole, rabeprazole(concomitant), then the eradication rate of concomitant group will be the highest.

详细描述

  • Subject: The patient of gastritis, gastric ulcer, and duodenal ulcer infected with Helicobacter pylori
  • 170 subjects per group
  • Eradication regimens are as follows: AOC group, treated with amoxicillin, rabeprazole, clarithromycin for 7 days; AOM group, treated with amoxicillin, rabeprazole, metronidazole for 7 days; sequential group, treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days; concomitant group, treated with amoxicillin, clarithromycin, metronidazole, rabeprazole for 7 days

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients infected with Helicobacter pylori

排除标准

  • pregnancy
  • formerly treated with eradication

研究组 & 干预措施

AOC group

Experimental

AOC group: treated with amoxicillin, rabeprazole, clarithromycin for 7 days

干预措施: amoxicillin, clarithromycin, metronidazole, rabeprazole (Drug)

AOM group

Experimental

AOM group: treated with amoxicillin, rabeprazole, metronidazole for 7 days

干预措施: amoxicillin, clarithromycin, metronidazole, rabeprazole (Drug)

Sequential group

Experimental

Sequential group: treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days

干预措施: amoxicillin, clarithromycin, metronidazole, rabeprazole (Drug)

concomitant group

Experimental

concomitant group: treated with amoxicillin, clarithromycin, metronidazole, rabeprazole for 7 days

干预措施: amoxicillin, clarithromycin, metronidazole, rabeprazole (Drug)

结局指标

主要结局

Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori

时间窗: 6 months (Feb 2014)

measure eradication rate of H.pylori with urea breath test(UBT) after 6 to 8 weeks of treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin Il Kim

MD, PhD

The Catholic University of Korea

研究点 (1)

Loading locations...

相似试验